Muscle News and Research

RSS

New study: Rapamycin reverses cardiac muscle damage in LEOPARD syndrome mouse model

Congenital heart diseases affect approximately one in 100 patients, making them the most common type of birth defect and the number-one cause of pediatric deaths.

21 Feb 2011

Amphetamine linked to development of Parkinson’s disease

New research suggests that taking prescription amphetamines may raise the risk of developing Parkinson’s disease later. But, the researchers noted that the study did not prove a cause-and-effect relationship and further investigation is warranted. The research was released Feb. 19, and is scheduled to be presented in April at the American Academy of Neurology’s annual meeting in Honolulu.

21 Feb 2011

International study shows reprogramming cells lead to genomic aberrations

It's a discordant note in the symphony of good news that usually accompanies stem cell research announcements. Stem cells hold enormous promise in regenerative medicine, thanks to their ability to regenerate diseased or damaged tissues.

21 Feb 2011

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

James C. Wittig, M.D., chief of the division of skin and sarcoma cancer at the John Theurer Cancer Center at Hackensack University Medical Center will present eleven different educational videos on innovative approaches to orthopedic oncology at the upcoming American Academy of Orthopaedic Surgeons Conference.

20 Feb 2011

Scientists decode DNA of parasitic worm that causes trichinosis

Scientists have decoded the DNA of the parasitic worm that causes trichinosis, a disease linked to eating raw or undercooked pork or carnivorous wild game animals, such as bear and walrus.

20 Feb 2011

New research demonstrates how climate change can increase exposure, risk of human illness

A panel of scientists speaking today at the annual meeting of the American Association for the Advancement of Science unveiled new research and models demonstrating how climate change could increase exposure and risk of human illness originating from ocean, coastal and Great Lakes ecosystems, with some studies projecting impacts to be felt within 30 years.

20 Feb 2011

Chronic fatigue syndrome – eased by psychotherapy: Study

New British research suggests that people with chronic fatigue syndrome may be helped the most when standard treatment is coupled with cognitive behaviour therapy or exercise therapy.

20 Feb 2011

New study identifies factors that predict dancer ability to return to work after hip arthroscopy

A new study has identified factors that predict the ability of a professional dancer to return to professional performance after hip arthroscopy surgery. The study by Hospital for Special Surgery investigators will be presented at the American Academy of Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San Diego, Calif.

19 Feb 2011

Study: Low levels of Klotho protein may serve as early warning sign of CKD

Low levels of the anti-aging hormone Klotho may serve as an early warning sign of the presence of kidney disease and its deadly cardiovascular complications, according to findings by UT Southwestern Medical Center researchers.

18 Feb 2011

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Endo Pharmaceuticals and Bioniche Life Sciences Inc. today announced plans for peer-reviewed presentation of interim efficacy and safety results from the first Phase III trial of the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™ or EN3348.

18 Feb 2011

Study: Stretching before running neither prevents nor causes injury

Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

18 Feb 2011

Opinions: U.S. foreign aid; Lay health workers

"The international affairs budget does more than just keep our nation safe - it bolsters our economy by creating jobs here and developing markets for U.S. goods and services overseas. It makes sense: effective development brings stability, economic development and a demand for goods and services," according to a Politico opinion piece by Reps. Gerald Connolly (D-Va.) and Leonard Lance (R-N.J.).

18 Feb 2011

Signs of P.A.D. indicate increased risk of heart disease, heart attack, death

Approximately nine million Americans over the age of 50 are living with a disease that affects their legs and raises their risk of having a heart attack. Unfortunately, many with the disease do not even know they have it. February is Heart Month, and the Vascular Disease Foundation and its P.A.D. Coalition are urging Americans to listen to their legs and be alert to the signs of peripheral arterial disease, or P.A.D.

18 Feb 2011

FDA grants miRagen's MGN-4893 orphan drug designation for treatment of polycythemia vera

miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.

18 Feb 2011

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2010.

17 Feb 2011

Muscle, aptly enough, is born of cellular bullying, and not mutual consent

In fact, according to new research from Johns Hopkins, the fusion of muscle cells is a power struggle that involves a smaller mobile antagonist that points at, pokes and finally pushes into its larger, stationary partner using a newly identified finger-like projection.

17 Feb 2011

Amicus to present additional positive data from Amigal Phase 2 extension study for Fabry disease

Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.

17 Feb 2011

Endo Pharmaceuticals, Bioniche announce first patient enrollment in Urocidin second Phase III trial

Endo Pharmaceuticals and Bioniche Life Sciences Inc., today announced enrollment of the first patient in the second Phase III clinical trial of Urocidin.

16 Feb 2011

Mutations in gene linked to structure of the heart seen in Ebstein's anomaly patients

Ebstein's anomaly is a rare congenital valvular heart disease. Now, in patients with this disease, researchers of the Academic Medical Center Amsterdam in the Netherlands, the University of Newcastle, UK and the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have identified mutations in a gene which plays an important role in the structure of the heart.

16 Feb 2011

Researchers identify cell of origin for sarcoma

Researchers at Oregon Health & Science University Doernbecher Children's Hospital have defined the cell of origin for a kind of cancer called sarcoma. In a study published today as the Featured Article in the journal Cancer Cell, they report that childhood and adult sarcomas are linked in their biology, mutations and the cells from which these tumors first start.

16 Feb 2011

Muscle News and Research

New study: Rapamycin reverses cardiac muscle damage in LEOPARD syndrome mouse model

Amphetamine linked to development of Parkinson’s disease

International study shows reprogramming cells lead to genomic aberrations

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

Scientists decode DNA of parasitic worm that causes trichinosis

New research demonstrates how climate change can increase exposure, risk of human illness

Chronic fatigue syndrome – eased by psychotherapy: Study

New study identifies factors that predict dancer ability to return to work after hip arthroscopy

Study: Low levels of Klotho protein may serve as early warning sign of CKD

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Study: Stretching before running neither prevents nor causes injury

Opinions: U.S. foreign aid; Lay health workers

Signs of P.A.D. indicate increased risk of heart disease, heart attack, death

FDA grants miRagen's MGN-4893 orphan drug designation for treatment of polycythemia vera

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Muscle, aptly enough, is born of cellular bullying, and not mutual consent

Amicus to present additional positive data from Amigal Phase 2 extension study for Fabry disease

Endo Pharmaceuticals, Bioniche announce first patient enrollment in Urocidin second Phase III trial

Mutations in gene linked to structure of the heart seen in Ebstein's anomaly patients

Researchers identify cell of origin for sarcoma

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News